SCNI
Scinai Immunotherapeutics
SCNI
SCNI
8 hedge funds and large institutions have $2.41M invested in Scinai Immunotherapeutics in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$2K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
II
1
Ibex Investors
Denver,
Colorado
| $2.14M | – | – | – |
|
|
BHB
2
Bank Hapoalim BM
Tel Aviv,
Israel
| $148K | – | – | – |
|
3
HighTower Advisors
Chicago,
Illinois
| $96K | – | – | – |
|
|
LTFS
4
Ladenburg Thalmann Financial Services
Miami,
Florida
| $14K | – | – | – |
|
5
Wells Fargo
San Francisco,
California
| $5K | – | – | – |
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $5K | – | – | – |
|
7
Morgan Stanley
New York
| $4K | – | – | – |
|
|
8
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $2K | +$2K | +5 | New |
|